HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · IEX Real-Time Price · USD
2.950
+0.470 (18.95%)
At close: Jul 2, 2024, 4:00 PM
3.000
+0.050 (1.69%)
After-hours: Jul 2, 2024, 7:53 PM EDT
HeartBeam Market Cap
HeartBeam has a market cap or net worth of $77.67 million as of July 2, 2024. Its market cap has increased by 22.90% in one year.
Market Cap
77.67M
Enterprise Value
65.03M
1-Year Change
22.90%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since the IPO on November 11, 2021, HeartBeam's market cap has increased from $46.53M to $77.67M, an increase of 66.93%. That is a compound annual growth rate of 21.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 65.30M | 5.49% |
| Dec 29, 2023 | 61.90M | 58.31% |
| Dec 30, 2022 | 39.10M | 62.24% |
| Dec 31, 2021 | 24.10M | -48.20% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 80.77M |
| Ikena Oncology | 78.66M |
| Affimed | 78.50M |
| T2 Biosystems | 78.06M |
| IO Biotech | 77.74M |
| Chimerix | 77.31M |
| Checkpoint Therapeutics | 77.00M |
| Connect Biopharma Holdings | 76.04M |